BioCentury
ARTICLE | Company News

Aventis vaccine deal with FibroGen

January 18, 2001 8:00 AM UTC

Aventis (AVE) vaccine division Aventis Pasteur and FibroGen (South San Francisco, Calif.) will develop synthetic gelatins in yeast for use as stabilizers in vaccines. Denatured collagen (gelatin) is c...